Wichita, KS, June 29, 2011 --(PR.com
)-- Research by Dr. David A. Jernigan D.C., D.N.M, Points to Expanded Treatment Focus.
Clinical research done by doctors at the Hansa Center for Optimum Health, suggests that in many of the people who experience long-term recovery from chronic Lyme disease (CLD) the bacteria and co-infections played only a secondary role in their recovery.
Dr. David A. Jernigan’s latest article in the July issue of Townsend Letter’s Examiner of Alternative Medicine Publication, proposes a bio-centric, instead of microbe-centric focus in the treatment of people suffering from what is generally called CLD.
While many doctors and people can point to remissions in individuals, brought about by antibiotic-type treatments, the ultimate role played by these drugs and supplements is over-glamorized, while the restorative functions of the human body is downplayed or ignored altogether. Health restoration is a function of the body, not a function of a drug.
In an illness where all Lyme disease (LD) laboratory tests demonstrate a high, false-negative rate, even in profoundly sick LD cases, the extensive antibiotic treatment and subsequent finding of a negative lab test means very little to validate the effectiveness of the treatment.
In Dr. Jernigan’s interviewing of thousands of people treated with long-term, natural, and conventional antibacterial medications, the vast majority of people report that they have nowhere near the quality of life they once enjoyed.
Once the diagnosis of Lyme disease is made, 99% of doctors focus their primary efforts toward annihilating the bacteria and co-infections, and all of the other treatments revolve around that primary focus. While bringing down the population of offending microbes is important, their complete annihilation is not ultimately what creates the restoration of optimum health.
According to Dr. Jernigan, “In chronic Lyme disease especially, we have found that the center of focus must be placed on restoring optimum coherence within the body, with the microbial issues being addressed as a secondary focus.”
For the full article in July’s Townsend Letter, please visit http://www.townsendletter.com. For an interview with Dr. Jernigan, please contact Keeley Dodd at 316-686-5900 ext.1 or email at firstname.lastname@example.org.